{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:02:04Z","timestamp":1789714924485,"version":"4.0.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"DOI":"10.1038\/s41401-026-01926-2","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:07:42Z","timestamp":1789711662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tectorigenin alleviates HFpEF by targeting the EGFR-EGR2-Acot1 axis to improve myocardial lipid metabolism"],"prefix":"10.1038","author":[{"given":"Li-guo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-zhen","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-jie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-feng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-lei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-sheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-ting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"1926_CR1","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599\u2013726.","journal-title":"Eur Heart J"},{"key":"1926_CR2","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0140-6736(23)02756-3","volume":"403","author":"P Campbell","year":"2024","unstructured":"Campbell P, Rutten FH, Lee MMY, Hawkins NM, Petrie MC. Heart failure with preserved ejection fraction: everything the clinician needs to know. Lancet. 2024;403:1083\u201392.","journal-title":"Lancet"},{"key":"1926_CR3","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","volume":"14","author":"SM Dunlay","year":"2017","unstructured":"Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2017;14:591\u2013602.","journal-title":"Nat Rev Cardiol"},{"key":"1926_CR4","doi-asserted-by":"crossref","unstructured":"Martin N, Manoharan K, Davies C, Lumbers RT. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction. Cochrane Database Syst Rev. 2018;6:CD012721.","DOI":"10.1002\/14651858.CD012721.pub2"},{"key":"1926_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-med-042220-022745","volume":"73","author":"K Omote","year":"2022","unstructured":"Omote K, Verbrugge FH, Borlaug BA. Heart failure with preserved ejection fraction: mechanisms and treatment strategies. Annu Rev Med. 2022;73:321\u201337.","journal-title":"Annu Rev Med"},{"key":"1926_CR6","doi-asserted-by":"crossref","unstructured":"Fan Y, Yang Z, Wang L, Liu Y, Song Y, Liu Y, et al. Traditional Chinese medicine for heart failure with preserved ejection fraction: clinical evidence and potential mechanisms. Front Pharmacol. 2023;14:1154167.","DOI":"10.3389\/fphar.2023.1154167"},{"key":"1926_CR7","doi-asserted-by":"crossref","unstructured":"Rong J, Fu F, Han C, Wu Y, Xia Q, Du D. Tectorigenin: a review of its sources, pharmacology, toxicity, and pharmacokinetics. Molecules. 2023;28:5904.","DOI":"10.3390\/molecules28155904"},{"key":"1926_CR8","doi-asserted-by":"crossref","unstructured":"Ma R, Liu X, Zheng P, Zou G, Zhang C. Tectorigenin alleviates irinotecan-induced intestinal inflammation by activating the Nrf2\/Keap1 pathway and synergistically enhances the anti-colon cancer efficacy of irinotecan. Toxicol Appl Pharmacol. 2025;502:117416.","DOI":"10.1016\/j.taap.2025.117416"},{"key":"1926_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jtcme.2025.02.006","volume":"15","author":"L Xie","year":"2025","unstructured":"Xie L, Xiao S, Zhou Q, Chen W, Hu Z, Li Y, et al. Tectorigenin attenuates myocardial damage by doxorubicin-induced ferroptosis by activating the p62-Keap1-Nrf2\/HO-1\/GPX4 axis.\u00a0J Tradit Complement Med. 2025;15:573\u201381.","journal-title":"J Tradit Complement Med"},{"key":"1926_CR10","doi-asserted-by":"crossref","unstructured":"Chen X, Zhou G, Yuan T, He Z, Su L, Guo H, et al. Tectorigenin attenuates cardiac hypertrophy via USP9X\/MCL1-mediated mitochondrial stabilization. Redox Biol. 2025;86:103855.","DOI":"10.1016\/j.redox.2025.103855"},{"key":"1926_CR11","doi-asserted-by":"crossref","unstructured":"Ma YL, Xu M, Cen XF, Qiu HL, Guo YY, Tang QZ. Tectorigenin protects against cardiac fibrosis in diabetic mice heart via activating the adiponectin receptor 1-mediated AMPK pathway. Biomed Pharmacother. 2024;174:116589.","DOI":"10.1016\/j.biopha.2024.116589"},{"key":"1926_CR12","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1093\/cvr\/cvab149","volume":"118","author":"S Guo","year":"2022","unstructured":"Guo S, Okyere AD, McEachern E, Strong JL, Carter RL, Patwa VC, et al. Epidermal growth factor receptor-dependent maintenance of cardiac contractility. Cardiovasc Res. 2022;118:1276\u201388.","journal-title":"Cardiovasc Res"},{"key":"1926_CR13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1161\/CIRCRESAHA.122.322133","volume":"133","author":"S Alg\u00fcl","year":"2023","unstructured":"Alg\u00fcl S, Schuldt M, Manders E, Jansen V, Schlossarek S, de Goeij-de Haas R, et al. EGFR\/IGF1R signaling modulates relaxation in hypertrophic cardiomyopathy. Circ Res. 2023;133:387\u201399.","journal-title":"Circ Res"},{"key":"1926_CR14","doi-asserted-by":"crossref","unstructured":"Zheng X, Liu L, Liu J, Zhang C, Zhang J, Qi Y, et al. Fibulin7 mediated pathological cardiac remodeling through EGFR binding and EGFR-dependent FAK\/AKT signaling activation. Adv Sci (Weinh). 2023;10:e2207631.","DOI":"10.1002\/advs.202207631"},{"key":"1926_CR15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1161\/HYPERTENSIONAHA.115.06922","volume":"67","author":"Y Honda","year":"2016","unstructured":"Honda Y, Shishido T, Takahashi T, Watanabe T, Netsu S, Kinoshita D, et al. Midkine deteriorates cardiac remodeling via epidermal growth factor receptor signaling in chronic kidney disease. Hypertension. 2016;67:857\u201365.","journal-title":"Hypertension"},{"key":"1926_CR16","doi-asserted-by":"crossref","unstructured":"Li W, Fang Q, Zhong P, Chen L, Wang L, Zhang Y, et al. EGFR inhibition blocks palmitic acid-induced inflammation in cardiomyocytes and prevents hyperlipidemia-induced cardiac injury in mice. Sci Rep. 2016;6:24580.","DOI":"10.1038\/srep24580"},{"key":"1926_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.tem.2017.03.001","volume":"28","author":"V Tillander","year":"2017","unstructured":"Tillander V, Alexson SEH, Cohen DE. Deactivating fatty acids: Acyl-CoA thioesterase-mediated control of lipid metabolism. Trends Endocrinol Metab. 2017;28:473\u201384.","journal-title":"Trends Endocrinol Metab"},{"key":"1926_CR18","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.2337\/db16-1519","volume":"66","author":"MP Franklin","year":"2017","unstructured":"Franklin MP, Sathyanarayan A, Mashek DG. Acyl-CoA thioesterase 1 (ACOT1) regulates PPAR\u03b1 to couple fatty acid flux with oxidative capacity during fasting. Diabetes. 2017;66:2112\u201323.","journal-title":"Diabetes"},{"key":"1926_CR19","doi-asserted-by":"crossref","unstructured":"Peng T, Yang S, Chen C, Wang H, Rao X, Wang F, et al. Protective effects of Acyl-coA thioesterase 1 on diabetic heart via PPAR\u03b1\/PGC1\u03b1 signaling. PLoS One. 2012;7:e50376.","DOI":"10.1371\/journal.pone.0050376"},{"key":"1926_CR20","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.bbrc.2015.10.078","volume":"468","author":"C Xia","year":"2015","unstructured":"Xia C, Dong R, Chen C, Wang H, Wang DW. Cardiomyocyte specific expression of Acyl-coA thioesterase 1 attenuates sepsis induced cardiac dysfunction and mortality. Biochem Biophys Res Commun. 2015;468:533\u201340.","journal-title":"Biochem Biophys Res Commun"},{"key":"1926_CR21","doi-asserted-by":"crossref","unstructured":"Liu Y, Zeng L, Yang Y, Chen C, Wang D, Wang H. Acyl-CoA thioesterase 1 prevents cardiomyocytes from doxorubicin-induced ferroptosis via shaping the lipid composition. Cell Death Dis. 2020;11:756.","DOI":"10.1038\/s41419-020-02948-2"},{"key":"1926_CR22","doi-asserted-by":"crossref","unstructured":"Yu Y, Ji Y, Liu Y, Liu B, Zhang J, Liu W, et al. Myocardial rhythm-mediated lipid metabolic dysfunction participates in adverse cardiac remodeling in offspring exposed to PM2.5 during conception. Ecotoxicol Environ Saf. 2025;306:119349.","DOI":"10.1016\/j.ecoenv.2025.119349"},{"key":"1926_CR23","doi-asserted-by":"crossref","unstructured":"Daou D, Tong D, Schiattarella GG, Gillette TG, Hill JA. What is cardiometabolic HFpEF and how can we study it preclinically? JACC Basic Transl Sci. 2025;10:101295.","DOI":"10.1016\/j.jacbts.2025.04.009"},{"key":"1926_CR24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","volume":"568","author":"GG Schiattarella","year":"2019","unstructured":"Schiattarella GG, Altamirano F, Tong D, French KM, Villalobos E, Kim SY, et al. Nitrosative stress drives heart failure with preserved ejection fraction. Nature. 2019;568:351\u20136.","journal-title":"Nature"},{"key":"1926_CR25","doi-asserted-by":"publisher","first-page":"14727","DOI":"10.1021\/acs.jafc.4c02379","volume":"72","author":"R Liu","year":"2024","unstructured":"Liu R, Jiang L, Chen Y, Shao J, Chen K, Li X, et al. Ginsenoside-Rh2 promotes functional recovery after spinal cord injury by enhancing tfeb-mediated autophagy. J Agric Food Chem. 2024;72:14727\u201346.","journal-title":"J Agric Food Chem"},{"key":"1926_CR26","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1002\/ptr.8469","volume":"39","author":"Z Long","year":"2025","unstructured":"Long Z, Huang Y, Lin T, Xiao S, Chen K, Ying J, et al. Emodin promotes peripheral nerve repair by modulating inflammasome activation through autophagy via the EGFR\/PI3K\/AKT\/mTOR pathway. Phytother Res. 2025;39:2324\u201338.","journal-title":"Phytother Res"},{"key":"1926_CR27","doi-asserted-by":"crossref","unstructured":"Villalba-Orero M, Garcia-Pavia P, Lara-Pezzi E. Non-invasive assessment of HFpEF in mouse models: current gaps and future directions. BMC Med. 2022;20:349.","DOI":"10.1186\/s12916-022-02546-3"},{"key":"1926_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/cvr\/cvaa110","volume":"117","author":"S Zacchigna","year":"2021","unstructured":"Zacchigna S, Paldino A, Falc\u00e3o-Pires I, Daskalopoulos EP, Dal Ferro M, Vodret S, et al. Towards standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function. Cardiovasc Res. 2021;117:43\u201359.","journal-title":"Cardiovasc Res"},{"key":"1926_CR29","doi-asserted-by":"crossref","unstructured":"Small L, Ehrlich A, Iversen J, Ashcroft SP, Tro\u0161t K, Moritz T, et al. Comparative analysis of oral and intraperitoneal glucose tolerance tests in mice. Mol Metab. 2022;57:101440.","DOI":"10.1016\/j.molmet.2022.101440"},{"key":"1926_CR30","doi-asserted-by":"crossref","unstructured":"Lin K, Wei W, Chen S, Gong Y, Wang X, Wang M, et al. Asb10 accelerates pathological cardiac remodeling by stabilizing HSP70. Cell Death Dis. 2025;16:409.","DOI":"10.1038\/s41419-025-07735-5"},{"key":"1926_CR31","doi-asserted-by":"crossref","unstructured":"Judd J, Lovas J, Huang GN. Isolation, culture and transduction of adult mouse cardiomyocytes. J Vis Exp. 2016;(114):54012.","DOI":"10.3791\/54012-v"},{"key":"1926_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41592-024-02480-7","volume":"22","author":"JK Ewoldt","year":"2024","unstructured":"Ewoldt JK, DePalma SJ, Jewett ME, Karakan M\u00c7, Lin YM, Mir Hashemian P, et al. Induced pluripotent stem cell-derived cardiomyocyte in vitro models: benchmarking progress and ongoing challenges. Nat Methods. 2024;22:24\u201340.","journal-title":"Nat Methods"},{"key":"1926_CR33","doi-asserted-by":"crossref","unstructured":"Zhang Y, Zhang J, Li M, Qiao Y, Wang W, Ma L, et al. Target discovery of bioactive natural products with native-compound-coupled CNBr-activated Sepharose 4B beads (NCCB): Applications, mechanisms and outlooks. Bioorg Med Chem. 2023;96:117483.","DOI":"10.1016\/j.bmc.2023.117483"},{"key":"1926_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrg2918","volume":"12","author":"A-L Barab\u00e1si","year":"2010","unstructured":"Barab\u00e1si AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet. 2010;12:56\u201368.","journal-title":"Nat Rev Genet"},{"key":"1926_CR35","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/nprot.2016.051","volume":"11","author":"S Forli","year":"2016","unstructured":"Forli S, Huey R, Pique ME, Sanner MF, Goodsell DS, Olson AJ. Computational protein\u2013ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc. 2016;11:905\u201319.","journal-title":"Nat Protoc"},{"key":"1926_CR36","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00395-025-01144-7","volume":"120","author":"PE McCallinhart","year":"2025","unstructured":"McCallinhart PE, Strawser CH, Garfinkle EAR, Navarro JB, McAllister C, Vetter TA, et al. Single cell and spatial transcriptomic profiling of the type 2 diabetic coronary microcirculation and myocardium. Basic Res Cardiol. 2025;120:1109\u201329.","journal-title":"Basic Res Cardiol"},{"key":"1926_CR37","doi-asserted-by":"publisher","first-page":"20488","DOI":"10.1074\/jbc.M112.447250","volume":"288","author":"A Chandra","year":"2013","unstructured":"Chandra A, Lan S, Zhu J, Siclari VA, Qin L. Epidermal growth factor receptor (EGFR) signaling promotes proliferation and survival in osteoprogenitors by increasing early growth response 2 (EGR2) expression. J Biol Chem. 2013;288:20488\u201398.","journal-title":"J Biol Chem"},{"key":"1926_CR38","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s12265-025-10602-5","volume":"18","author":"X Hou","year":"2025","unstructured":"Hou X, Hu G, Wang H, Yang Y, Sun Q, Bai X. Inhibition of Egr2 protects against tac-induced heart failure in mice by suppressing inflammation and apoptosis via targeting acot1 in cardiomyocytes. J Cardiovasc Transl Res. 2025;18:574\u201385.","journal-title":"J Cardiovasc Transl Res"},{"key":"1926_CR39","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1002\/ejhf.3676","volume":"27","author":"G Savarese","year":"2025","unstructured":"Savarese G, Schiattarella GG, Lindberg F, Anker MS, Bayes-Genis A, B\u00e4ck M, et al. Heart failure and obesity: translational approaches and therapeutic perspectives. A scientific statement of the Heart Failure Association of the ESC. Eur J Heart Fail. 2025;27:1273\u201393.","journal-title":"Eur J Heart Fail"},{"key":"1926_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/eurheartj\/ehaf524","volume":"47","author":"A Peikert","year":"2026","unstructured":"Peikert A, Fontana M, Solomon SD, Thum T. Left ventricular hypertrophy and myocardial fibrosis in heart failure with preserved ejection fraction: mechanisms and treatment. Eur Heart J. 2026;47:37\u201353.","journal-title":"Eur Heart J"},{"key":"1926_CR41","doi-asserted-by":"crossref","unstructured":"Jankowski J, Kozub KO, Kleibert M, Camlet K, Kleibert K, Cudnoch-J\u0119drzejewska A. The role of programmed types of cell death in pathogenesis of heart failure with preserved ejection fraction. Int J Mol Sci. 2024;25:9921.","DOI":"10.3390\/ijms25189921"},{"key":"1926_CR42","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tsch\u00f6pe C. A novel paradigm for heart failure with preserved ejection fraction. J Am Coll Cardiol. 2013;62:263\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"1926_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41401-023-01152-0","volume":"45","author":"S Gao","year":"2023","unstructured":"Gao S, Liu XP, Li TT, Chen L, Feng YP, Wang YK, et al. Animal models of heart failure with preserved ejection fraction (HFpEF): from metabolic pathobiology to drug discovery. Acta Pharmacol Sin. 2023;45:23\u201335.","journal-title":"Acta Pharmacol Sin"},{"key":"1926_CR44","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1038\/s41401-024-01341-5","volume":"45","author":"Y-l Han","year":"2024","unstructured":"Han YL, Yan TT, Li HX, Chen SS, Zhang ZZ, Wang MY, et al. Geniposide alleviates heart failure with preserved ejection fraction in mice by regulating cardiac oxidative stress via MMP2\/SIRT1\/GSK3\u03b2 pathway. Acta Pharmacol Sin. 2024;45:2567\u201378.","journal-title":"Acta Pharmacol Sin"},{"key":"1926_CR45","doi-asserted-by":"crossref","unstructured":"Zhang K, Gan J, Wang B, Lei W, Zhen D, Yang J, et al. FGF21 protects against HFpEF by improving cardiac mitochondrial bioenergetics in mice. Nat Commun. 2025;16:1661.","DOI":"10.1038\/s41467-025-56885-9"},{"key":"1926_CR46","doi-asserted-by":"crossref","unstructured":"Abudureyimu M, Luo X, Jiang L, Jin X, Pan C, Yu W, et al. FBXL4 protects against HFpEF through Drp1-mediated regulation of mitochondrial dynamics and the downstream SERCA2a. Redox Biol. 2024;70:103081.","DOI":"10.1016\/j.redox.2024.103081"},{"key":"1926_CR47","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1161\/CIRCRESAHA.124.325310","volume":"136","author":"S Costantino","year":"2025","unstructured":"Costantino S, Mohammed SA, Ambrosini S, Telesca M, Mengozzi A, Walavalkar K, et al. Chromatin rewiring by SETD2 drives lipotoxic injury in cardiometabolic HFpEF. Circ Res. 2025;136:1079\u201395.","journal-title":"Circ Res"},{"key":"1926_CR48","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.bbalip.2016.02.016","volume":"1861","author":"K D\u2019Souza","year":"2016","unstructured":"D\u2019Souza K, Nzirorera C, Kienesberger PC. Lipid metabolism and signaling in cardiac lipotoxicity.\u00a0Biochim Biophys Acta. 2016;1861:1513-24.","journal-title":"Biochim Biophys Acta"},{"key":"1926_CR49","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1161\/CIRCULATIONAHA.124.072194","volume":"151","author":"O Fonseka","year":"2025","unstructured":"Fonseka O, Raja R, Ross C, Gare SR, Zhang J, Hille SS, et al. XBP1s-EDEM2 prevents the onset and development of HFpEF by ameliorating cardiac lipotoxicity. Circulation. 2025;151:1583\u2013605.","journal-title":"Circulation"},{"key":"1926_CR50","doi-asserted-by":"crossref","unstructured":"Wang M, Wang L, Zhou L, Xu Y, Wang C. Shen-Shuai-II-Recipe inhibits tubular inflammation by PPAR\u03b1-mediated fatty acid oxidation to attenuate fibroblast activation in fibrotic kidneys. Phytomedicine. 2024;126:155450.","DOI":"10.1016\/j.phymed.2024.155450"},{"key":"1926_CR51","doi-asserted-by":"crossref","unstructured":"Lozhkin A, Vendrov AE, Ramos-Mondrag\u00f3n R, Canugovi C, Stevenson MD, Herron TJ, et al. Mitochondrial oxidative stress contributes to diastolic dysfunction through impaired mitochondrial dynamics. Redox Biol. 2022;57:102474.","DOI":"10.1016\/j.redox.2022.102474"},{"key":"1926_CR52","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1161\/CIRCRESAHA.123.324103","volume":"135","author":"A Yoshii","year":"2024","unstructured":"Yoshii A, McMillen TS, Wang Y, Zhou B, Chen H, Banerjee D, et al. Blunted cardiac mitophagy in response to metabolic stress contributes to HFpEF. Circ Res. 2024;135:1004\u201317.","journal-title":"Circ Res"},{"key":"1926_CR53","doi-asserted-by":"crossref","unstructured":"Wang S, Kang Y, Wang R, Deng J, Yu Y, Yu J, et al. Emerging roles of NDUFS8 located in mitochondrial complex I in different diseases. Molecules. 2022;27:8754.","DOI":"10.3390\/molecules27248754"},{"key":"1926_CR54","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1161\/CIRCRESAHA.121.318988","volume":"131","author":"X Wu","year":"2022","unstructured":"Wu X, Liu H, Brooks A, Xu S, Luo J, Steiner R, et al. SIRT6 mitigates heart failure with preserved ejection fraction in diabetes. Circ Res. 2022;131:926\u201343.","journal-title":"Circ Res"},{"key":"1926_CR55","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1042\/BST20140094","volume":"42","author":"O Abo Alrob","year":"2014","unstructured":"Abo Alrob O, Lopaschuk GaryD. Role of CoA and acetyl-CoA in regulating cardiac fatty acid and glucose oxidation. Biochem Soc Trans. 2014;42:1043\u201351.","journal-title":"Biochem Soc Trans"},{"key":"1926_CR56","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.1080\/07391102.2023.2229437","volume":"42","author":"HN Naik","year":"2023","unstructured":"Naik HN, Kanjariya D, Parveen S, Meena A, Ahmad I, Patel H, et al. Dalbergia sissoo phytochemicals as EGFR inhibitors: an in vitro and in silico approach. J Biomol Struct Dyn. 2023;42:5415\u201327.","journal-title":"J Biomol Struct Dyn"},{"key":"1926_CR57","doi-asserted-by":"crossref","unstructured":"Zhai J, Tan R, Yuan S, Che B, Xiong K, Lu L, et al. Unveiling tectorigenin: a novel ferroptosis inducer targeting EGFR in bladder cancer. Phytomedicine. 2025;148:157419.","DOI":"10.1016\/j.phymed.2025.157419"},{"key":"1926_CR58","doi-asserted-by":"crossref","unstructured":"Bian WH, Wang SH, Kang ZC, Xu Y, Li YN, Yang MZ, et al. Quercetin ameliorates doxorubicin-induced atrial fibrillation via EGFR-mediated restoration of autophagic flux. Phytomedicine. 2025;148:157357.","DOI":"10.1016\/j.phymed.2025.157357"},{"key":"1926_CR59","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1038\/s41401-024-01265-0","volume":"45","author":"XY Ni","year":"2024","unstructured":"Ni XY, Feng XJ, Wang ZH, Zhang Y, Little PJ, Cao Y, et al. Empagliflozin and liraglutide ameliorate HFpEF in mice via augmenting the Erbb4 signaling pathway. Acta Pharmacol Sin. 2024;45:1604\u201317.","journal-title":"Acta Pharmacol Sin"},{"key":"1926_CR60","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1530\/JOE-16-0636","volume":"234","author":"J Liu","year":"2017","unstructured":"Liu J, Gao F, Liu YF, Dou HT, Yan JQ, Fan ZM, et al. HB-EGF regulates Prss56 expression during mouse decidualization via EGFR\/ERK\/EGR2 signaling pathway. J Endocrinol. 2017;234:247\u201354.","journal-title":"J Endocrinol"},{"key":"1926_CR61","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00441-014-1877-x","volume":"357","author":"Y Teramatsu","year":"2014","unstructured":"Teramatsu Y, Maeda H, Sugii H, Tomokiyo A, Hamano S, Wada N, et al. Expression and effects of epidermal growth factor on human periodontal ligament cells. Cell Tissue Res. 2014;357:633\u201343.","journal-title":"Cell Tissue Res"},{"key":"1926_CR62","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1007\/s12012-024-09909-7","volume":"24","author":"S Zhang","year":"2024","unstructured":"Zhang S, Jin P, Yang L, Zeng Y, Li Y, Tang R. Exploration of clozapine-induced cardiomyopathy and its mechanism. Cardiovasc Toxicol. 2024;24:1192\u2013203.","journal-title":"Cardiovasc Toxicol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01926-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01926-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01926-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:07:55Z","timestamp":1789711675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01926-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":62,"alternative-id":["1926"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01926-2","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"12 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All authors consented to publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}}]}}